Development of transfersomal buccal patches of galantamine for enhanced bioavailability in Alzheimer’s disease therapy
DOI:
https://doi.org/10.69857/joapr.v14i2.1523Keywords:
Galantamine, Transferosomes, Buccal patches, Mucoadhesive delivery, Alzheimer’s disease, Bioavailability enhancementAbstract
Background: Galantamine, an acetylcholinesterase inhibitor used in Alzheimer’s disease, exhibits low and variable bioavailability due to gastrointestinal metabolism and first-pass hepatic elimination. Buccal drug delivery offers a non-invasive route that bypasses first-pass metabolism and maintains systemic exposure. This work aimed to develop and evaluate transfersomal buccal patches of galantamine to enhance permeation and control release. Methodology: Galantamine-loaded transfersomes were prepared by thin-film hydration using phosphatidylcholine and edge activators, then incorporated into a mucoadhesive polymer matrix (PVA/HPMC/Carbopol/Eudragit L-100) via solvent casting. Formulations were characterized for vesicle size, zeta potential, deformability, entrapment efficiency, physicochemical properties, swelling, mucoadhesion, in vitro release, ex vivo buccal permeation, and stability. Result and Discussion: Transfersomes exhibited a mean size of 126.4 ± 4.8 nm, PDI ≈ 0.21, zeta potential −32.6 ± 1.4 mV, and entrapment efficiency 86.7 ± 2.5%. Optimized patches showed uniform thickness, high folding endurance (>300), drug-content uniformity (≈95–98%), and strong mucoadhesive strength, with PEG-plasticized films demonstrating superior swelling and residence time. Drug release followed diffusion-controlled (Higuchi-type) kinetics with near-zero-order behavior. Ex vivo permeation revealed a 2.5-fold increase in steady-state flux (3.21 ± 0.18 µg/cm²/h) and a higher permeability coefficient compared with the conventional oral formulation. Accelerated and saliva stability studies indicated no significant physicochemical changes. Conclusion: The integration of deformable transfersomes within a mucoadhesive buccal matrix enabled sustained diffusion-controlled delivery, significantly enhancing mucosal permeation. The transfersomal buccal patch represents a promising alternative to oral galantamine therapy, warranting in vivo pharmacokinetic and clinical evaluation.
Downloads
References
Malhotra S, Lijnse T, O’Cearbhaill E, Brayden DJ Devices to overcome the buccal mucosal barrier: physical-device strategies for peptide therapeutics. Int J Pharm, 663, 122200 (2025) https://doi.org/10.1016/j.ijpharm.2025.122200
Yuktha HJ, Gururaj SK, Paarakh MP. Mucoadhesive buccal films. J Community Pharm Pract, 3(5), 24–37 (2023) https://doi.org/10.55529/jcpp.35.24.37
Salamat-Miller N, Chittchang M, Johnston TP The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev, 57(11), 1666–1691 (2005) https://doi.org/10.1016/j.addr.2005.07.003
Wong WF, Chang SL, Ting YH, Weng YT, Liao YH, Chen YC, et al Recent advancement of medical patch for transdermal drug delivery. Medicina, 59(4), 778 (2023) https://doi.org/10.3390/medicina59040778
Bonetti L, Caprioglio A, Bono N, Candiani G, Altomare L Mucoadhesive chitosan-methylcellulose oral patches for the treatment of local mouth bacterial infections. Biomater Sci, 11(3), 856–866 (2023) https://doi.org/10.1039/D2BM01540D
Kumar R, Islam T, Nurunnabi M. Mucoadhesive carriers for oral drug delivery. J Control Release, 351(1), 504–559 (2022) https://doi.org/10.1016/j.jconrel.2022.09.024
Zhou H, Wang X, Liu J, Fan Q, Zhang Y, Wang Z, et al Hierarchical adhesive hydrogel microparticles with galantamine hydrobromide for enhanced cognitive function. Mater Sci Eng C, 155, 115620 (2024) https://doi.org/10.1016/j.msec.2024.115620
Arpa MD, Blanco-Méndez R, Pérez-Fernández A, Aguilar-Lopez S, Martín-Sabroso C, Molina-García JA Chitosan-based buccal mucoadhesive patches to enhance drug permeability ex vivo. Int J Biol Macromol, 233, 123589 (2023) https://doi.org/10.1016/j.ijbiomac.2023.123589
Pandey P, Khuller GK Nanostructured lipid carriers for improved dermal/transdermal and mucosal delivery. J Control Release, 125(3), 193–199 (2008) https://doi.org/10.1016/j.jconrel.2007.10.024
Samanthula KS, Bairi AG, Kothapally D Transbuccal drug delivery systems: a comprehensive review of recent approaches. J Young Pharm, 17(3), 495–503 (2025) https://doi.org/10.5530/jyp.20251309
Srivastava N, Aslam S Recent advancements and patents on buccal drug delivery systems: a comprehensive review. Recent Pat Nanotechnol, 15(4), 312–325 (2021) https://doi.org/10.2174/1872210515999210507120011
Shipp L, Wolff M, Ahmed W Buccal films: therapeutic opportunities and delivery technologies. Int J Pharm, 630, 122390 (2022) https://doi.org/10.1016/j.ijpharm.2022.122390
Shirvan AR, Hemmatinejad N, Bahrami S, Bashari A Fabrication of multifunctional mucoadhesive buccal patch for drug delivery applications. J Biomed Mater Res A, 109(10), 1903–1915 (2021) https://doi.org/10.1002/jbm.a.37178
Lodder RA, Craig DQM, Royall PG Buccal drug delivery systems and mechanical technologies: a review. Eur J Pharm Biopharm, 70(1), 166–178 (2008) https://doi.org/10.1016/j.ejpb.2008.05.003
Hassan AA, ElMeshad AN, El-Nabarawi MA. Quality by Design-guided systematic development and optimization of mucoadhesive buccal films. Pharmaceutics, 15(10), 2375 (2023) https://doi.org/10.3390/pharmaceutics15102375
Shaikh AAN, Shaikh HGN, Gouthaman K. Formulation and evaluation of linagliptin mucoadhesive buccal patch. Int J Pharm Sci Res, 16(12), 3426–3437 (2025) https://doi.org/10.13040/IJPSR.0975-8232.16(12).3426-37
Das NG, Chaudhury A Fundamental aspect of buccal mucoadhesive drug delivery: a review. Drug Dev Ind Pharm, 28(6), 597–608 (2002) https://doi.org/10.1081/DDC-120003853
Vaidya A, Mitragotri S Ionic liquid-mediated delivery of insulin to buccal mucosa.
J Control Release, 322, 493–500 (2020) https://doi.org/10.1016/j.jconrel.2020.03.019
Shirvan AR, Bashari A, Hemmatinejad N New insight into fabrication of smart mucoadhesive buccal patches as controlled-drug delivery system. Eur Polym J, 118, 328–336 (2019) https://doi.org/10.1016/j.eurpolymj.2019.06.037
Mirza SS, Ahmad FJ, Patel RD, Khar RK, Ali M
Design, development and evaluation of buccal patches of diltiazem hydrochloride.
Pharmazie, 61(4), 329–333 (2006) https://doi.org/10.1691/ph.2006.4.5778
Golshani S, Vatanara A, Amin M. Recent advances in oral mucoadhesive drug delivery. J Pharm Pharm Sci, 25(1), 201–217 (2022) https://doi.org/10.18433/jpps32705
Kulkarni GS, Patil SV, Karajgi SR. Formulation and characterization of mucoadhesive buccal films of repaglinide. Res J Pharm Technol, 18(9), 4190–4196 (2025) https://doi.org/10.52711/0974-360X.2025.00602
Sabareesh M, Aravind BR, Meenakshi B, Reddy YP. Nanoparticles loaded mucoadhesive buccal patches – a review. J Pharm Res Int, 34(46B), 24–38 (2022) https://doi.org/10.9734/jpri/2022/v34i46B36343
Huang Y, Leobandung W, Foss AJ, Peppas NA Molecular aspects of mucoadhesion and mucoadhesive drug delivery systems. J Control Release, 65(1–2), 63–71 (2000) https://doi.org/10.1016/S0168-3659(99)00207-5
Rawat D, Joshi P, Ale Y, Jakhmola V. Mucoadhesive drug delivery system: formulation and evaluation models. Asian J Pharm Clin Res, 18(4), 12–18 (2025) https://doi.org/10.22159/ajpcr.2025v18i4.53983
Sudhakar Y, Kuotsu K, Bandyopadhyay AK Buccal bioadhesive drug delivery — a promising option for orally less efficient drugs. J Control Release, 114(1), 15–40 (2006) https://doi.org/10.1016/j.jconrel.2006.04.012
Andrews GP, Laverty TP, Jones DS Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm, 71(3), 505–518 (2009) https://doi.org/10.1016/j.ejpb.2008.09.028
Basilicata M, Scandurra A, Cervino D, Troiano L, Rapone E, Lanza G Oral health and use of novel transbuccal drug delivery systems in neurodegenerative disorders. Appl Sci, 13(8), 4974 (2023) https://doi.org/10.3390/app13084974
Pamlényi K, Regdon G, Nemes D, Fenyvesi F, Bácskay I, Kristó K Stability, permeability and cytotoxicity of buccal films in allergy treatment. Pharmaceutics, 14(5), 1048 (2022) https://doi.org/10.3390/pharmaceutics14051048
Kolli CS, Palem CR, Reddi S Preparation and characterization of buccal films of miconazole nitrate. Int J Pharm, 274(1–2), 231–242 (2004) https://doi.org/10.1016/j.ijpharm.2003.11.025
Jacob S, Dutt A, Gupta R, Nair M, Khanna S, Thomas L, et al An updated overview of patch and buccal drug delivery systems. Pharmaceutics, 13(8), 1233 (2021) https://doi.org/10.3390/pharmaceutics13081233
Bácskay I, Regdon G, Nemes D, Fenyvesi F, Kónya Z, Kristó K Bioavailability enhancement and formulation strategies for oral mucosal drug delivery. Pharmaceutics, 17(1), 18 (2025) https://doi.org/10.3390/pharmaceutics17010018
Southward J, Lee H, Thompson S, Roberts E, Young M, Smith R Exploring potential of mucoadhesive buccal films. Drug Dev Ind Pharm, 51(7), 1123–1131 (2025) https://doi.org/10.1080/03639045.2025.2467329
Bácskay I, Regdon G Jr, Nemes D, Fenyvesi F, Sovány T, Kristó K. Bioavailability enhancement and formulation technologies of oral mucosal dosage forms: a review. Pharmaceutics, 17(1), 18 (2025) https://doi.org/10.3390/pharmaceutics17010018
Špiljak B, Somogyi Škoc M, Rezić Meštrović I, Bašić K, Bando I, Šutej I. Targeting the oral mucosa: emerging drug delivery platforms and the therapeutic potential of glycosaminoglycans. Pharmaceutics, 17(9), 1212 (2025) https://doi.org/10.3390/pharmaceutics17091212
Mauceri ME, Coppini M, De Caro V, Di Prima G, Mauceri R, Panzarella V, et al. Mucoadhesive drug delivery systems for oral chronic inflammatory mucosal diseases. The future is already present. A systematic review. Oral Dis, (Ahead of print) 1–12 (2025) https://doi.org/10.1111/odi.70042
Sharma V, Mittal C, Shekhedwal S, Chaudhary V, Kumar S. Niosomes: an Extensive Analysis of Its Structure, Preparation, and Uses in Drug Delivery. Journal of Applied Pharmaceutical Research, 13, 36–44 (2025) https://doi.org/10.69857/joapr.v13i3.1000.
Piñol-Ripoll G, Salas Carrillo M, VIITAL-2S Study Group Clinicians’ perspectives of twice-weekly rivastigmine patches. Patient Prefer Adherence, 19, 1105–1118 (2025) https://doi.org/10.2147/PPA.S510634
Mercier F, Watanabe N, Nagel J, Lu C, Othman AA Pharmacokinetics of rivastigmine transdermal patch compared with oral capsules in healthy volunteers: a randomized, crossover study. Br J Clin Pharmacol, 70(4), 470–477 (2010) https://doi.org/10.1111/j.1365-2125.2009.03541.x
Alqahtani AS, AlShehri AA, Noman OM, Alyami HS, Hassan MM. Topical drug delivery in oral mucosal diseases: challenges, carriers and innovations – a comprehensive review. Biomed Pharmacology J, 18(3), 1521–1538 (2025) https://doi.org/10.13005/bpj/2907
Pamlényi K, Kristó K, Sovány T, Regdon G Jr. Development and evaluation of bioadhesive buccal films based on sodium alginate for allergy therapy. Heliyon, 8(8), e10364 (2022) https://doi.org/10.1016/j.heliyon.2022.e10364
Dinte E, Lupu A, Luca L, Mureșan A, Porav SA, Tomuță I, et al. In vitro and in vivo characterisation of a mucoadhesive buccal film loaded with doxycycline hyclate. Pharmaceutics, 15(2), 580 (2023) https://doi.org/10.3390/pharmaceutics15020580
Hu S, Pei X, Duan L, Zhu Z, Liu Y, Chen J, et al. A mussel-inspired film for adhesion to wet buccal tissue and efficient buccal drug delivery. Nat Commun, 12(1), 1689 (2021) https://doi.org/10.1038/s41467-021-21989-5
Nair AB, Al-Dhubiab BE, Shah J, Almulhim FA, Morsy MA, Foudah AI, et al. Design, development and in vivo performance of buccal films embedded with paliperidone-loaded nanostructured lipid carriers. Pharmaceutics, 15(11), 2530 (2023) https://doi.org/10.3390/pharmaceutics15112530
Viju A, Rajasekaran V, Thomas S PEG-based mucoadhesive nanotransfersomal films for enhanced buccal absorption. Colloids Surf B Biointerfaces, 235, 113765 (2024) https://doi.org/10.1016/j.colsurfb.2024.113765
Published
How to Cite
Issue
Section
Copyright (c) 2026 Pavuluri Chandrasekhar, Rajaganapathy Kaliyaperumal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
